AVEO PHARMACEUTICALS INC's ticker is and the CUSIP is 053588957. A total of 1 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $65,780 | -37.9% | 4,400 | -65.9% | 0.00% | – |
| Q3 2022 | $106,000 | +7.1% | 12,900 | -14.6% | 0.00% | – |
| Q2 2022 | $99,000 | +26.9% | 15,100 | +8.6% | 0.00% | – |
| Q1 2022 | $78,000 | -79.1% | 13,900 | -82.6% | 0.00% | – |
| Q4 2021 | $374,000 | -11.2% | 79,700 | +16.9% | 0.00% | – |
| Q3 2021 | $421,000 | -19.8% | 68,200 | -14.3% | 0.00% | -100.0% |
| Q2 2021 | $525,000 | +82.3% | 79,600 | +102.5% | 0.00% | – |
| Q1 2021 | $288,000 | -15.8% | 39,300 | -33.7% | 0.00% | -100.0% |
| Q4 2020 | $342,000 | +95.4% | 59,300 | +101.7% | 0.00% | 0.0% |
| Q3 2020 | $175,000 | -24.6% | 29,400 | -34.7% | 0.00% | 0.0% |
| Q2 2020 | $232,000 | +648.4% | 45,000 | +417.2% | 0.00% | – |
| Q1 2020 | $31,000 | – | 8,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |